We hypothesize that the classification could also be extended to upper urothelial tract carcinomas, a work ongoing in our Group, with 15/57 tumors (26.3%) showing CK5/6 immunoexpression (data not shown). The gene discussed is KRT5; the disease is renal pelvis/ureter urothelial carcinoma.